Pharma

Government Restricts Export Of Some Pharma Ingredients, Drugs

Government Restricts Export Of Some Pharma Ingredients, Drugs

Reuters | Tuesday March 03, 2020

Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

Reuters | Monday March 02, 2020

Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.

Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility

Cipla Shares Fall 6% After US Regulator's Warning Letter On Goa Facility

Edited by Sandeep Singh | Wednesday February 26, 2020

Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations.

Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On

Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On

Reuters | Friday February 14, 2020

An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Industry Body Calls For Reduction In GST On Active Pharmaceutical Ingredients

Industry Body Calls For Reduction In GST On Active Pharmaceutical Ingredients

Edited by Abhishek | Thursday January 16, 2020

Pharma formulations attract GST of 12 per cent whereas inputs active pharmaceutical ingredients (API) have GST of 18 per cent which has led to accumulation of Input tax Credit.

Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%

Sun Pharma Q2 Profit At Rs 1,064 Crore, Shares Jump Over 3%

Edited by Sandeep Singh | Thursday November 07, 2019

On the BSE, the Sun Pharma stock jumped as much as 3.15 per cent to Rs 441.00 apiece after the earnings announcement.

Dr Reddy's Laboratories Profit More Than Doubles To Rs 1,093 Crore In September Quarter

Dr Reddy's Laboratories Profit More Than Doubles To Rs 1,093 Crore In September Quarter

Edited by Sandeep Singh | Friday November 01, 2019

Shares in Dr Reddy's Laboratories rose as much as 1.66 per cent to Rs 2,829.00 apiece on the BSE after the earnings announcement by the drug maker.